Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1989-07-03
1992-11-10
Kepplinger, Esther L.
Chemistry: molecular biology and microbiology
Spore forming or isolating process
53038873, 435 724, 435813, C12N 520
Patent
active
051622246
ABSTRACT:
The present invention relates to a monoclonal antibody-and to the hybridoma that produces it-specific for a surface antigen of activated B cells and T cells transformed by the virus HTLV-I. The hybridoma has been deposited with the European Collection of Annimal Cell Cultures (ECACC) under the number 88062301.
REFERENCES:
patent: 4692405 (1987-09-01), Freedman et al.
patent: 4831117 (1989-05-01), Uckun
patent: 4845198 (1989-07-01), Urdal et al.
patent: 4855235 (1989-08-01), Takahashi et al.
T. Yokochi et al., J. Immunology, 1982, vol. 128, pp. 823-827.
A. S. Freedman et al., J. Immunology, 1987, vol. 139, pp. 3260-3267.
Banchereau Jacques F.
Valle Alain
Blasdale John H. G.
Kepplinger Esther L.
Mazer Edward H.
Nelson James R.
Schering Corporation
LandOfFree
Monoclonal antibodies specific for B cells and HTLV-I transforme does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antibodies specific for B cells and HTLV-I transforme, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies specific for B cells and HTLV-I transforme will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2291903